NOX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Chatswood, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
NOX has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company